Puma Biotechnology (PBYI) News Today → Did You Get Your Free Bitcoin Yet? (From Crypto Swap Profits) (Ad) Free PBYI Stock Alerts $4.62 -0.24 (-4.94%) (As of 04:00 PM ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineAnalysts Have Lowered Expectations For Puma Biotechnology, Inc. (NASDAQ:PBYI) After Its Latest Resultsfinance.yahoo.com - May 5 at 6:07 PMPuma Biotechnology First Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lagfinance.yahoo.com - May 4 at 4:11 PMPuma Biotechnology (NASDAQ:PBYI) Rating Increased to Buy at StockNews.commarketbeat.com - May 3 at 11:37 PMPuma Biotechnology (NASDAQ:PBYI) Stock Rating Reaffirmed by HC Wainwrightmarketbeat.com - May 3 at 9:51 PMBuy Rating Affirmed for Puma Biotechnology Amid Strong Q1 Performance and Promising Outlookmarkets.businessinsider.com - May 3 at 8:54 PMPuma Biotechnology, Inc. (NASDAQ:PBYI) Q1 2024 Earnings Call Transcriptfinance.yahoo.com - May 3 at 8:54 PMPuma Biotechnology Inc (PBYI) Q1 2024 Earnings Call Transcript Highlights: A Detailed Review of ...finance.yahoo.com - May 3 at 9:41 AMPuma Biotechnology (NASDAQ:PBYI) Share Price Crosses Above 200-Day Moving Average of $4.64americanbankingnews.com - May 3 at 3:14 AMPBYI Stock Earnings: Puma Biotechnology Beats EPS, Beats Revenue for Q1 2024investorplace.com - May 2 at 10:03 PMPuma Biotechnology Non-GAAP EPS of -$0.05 beats by $0.10, revenue of $43.8M misses by $5.25Mmsn.com - May 2 at 8:59 PMPuma Biotechnology Reports First Quarter Financial Resultsbusinesswire.com - May 2 at 4:05 PMPuma Biotechnology Q1 2024 Earnings Previewmsn.com - May 1 at 6:41 PMPuma Biotechnology is about to announce its earnings — here's what Wall Street expectsmarkets.businessinsider.com - May 1 at 1:19 PMIs Puma Biotechnology, Inc. (NASDAQ:PBYI) A High Quality Stock To Own?finance.yahoo.com - April 29 at 1:08 PMPBYI Crosses Above Average Analyst Targetnasdaq.com - April 24 at 9:20 PM7 Stocks Under $15 Predicted to Boom in the Next 2 Yearsinvestorplace.com - April 19 at 7:13 AMPuma Biotechnology to Host Conference Call to Discuss First Quarter 2024 Financial Resultsbusinesswire.com - April 18 at 4:15 PMPuma Biotechnology (NASDAQ:PBYI) Downgraded by StockNews.commarketbeat.com - April 10 at 2:18 AMPuma Biotechnology (NASDAQ:PBYI) shareholders have earned a 93% return over the last yearfinance.yahoo.com - April 8 at 11:29 AMEquities Analysts Issue Forecasts for Puma Biotechnology, Inc.'s FY2025 Earnings (NASDAQ:PBYI)marketbeat.com - April 5 at 8:52 AMPuma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)businesswire.com - April 3 at 5:30 PMStockNews.com Upgrades Puma Biotechnology (NASDAQ:PBYI) to "Buy"marketbeat.com - April 2 at 11:12 PMDo Puma Biotechnology's (NASDAQ:PBYI) Earnings Warrant Your Attention?finance.yahoo.com - March 22 at 10:12 AMQ1 2024 EPS Estimates for Puma Biotechnology, Inc. Decreased by Zacks Research (NASDAQ:PBYI)marketbeat.com - March 22 at 7:35 AMPuma Biotechnology, Inc. to Post FY2026 Earnings of $0.56 Per Share, Zacks Research Forecasts (NASDAQ:PBYI)marketbeat.com - March 21 at 8:36 AMPuma Biotechnology (NASDAQ:PBYI) Share Price Crosses Above Two Hundred Day Moving Average of $4.13marketbeat.com - March 21 at 3:11 AMPuma Biotechnology: FDA Allows To Proceed With Clinical Development Of Alisertibmarkets.businessinsider.com - March 20 at 5:05 PMPuma Biotechnology Announces FDA Allowance to Proceed Under IND for Alisertib in HER2-Negative, Hormone Receptor-Positive Metastatic Breast Cancerfinance.yahoo.com - March 20 at 5:05 PMBuy Rating on Puma Biotechnology Amid Financial Challenges and Drug Advancement Prospectsmarkets.businessinsider.com - March 2 at 8:12 AMPuma Biotechnology, Inc. (NASDAQ:PBYI) Shares Could Be 47% Below Their Intrinsic Value Estimatefinance.yahoo.com - March 2 at 8:12 AMPuma Biotechnology, Inc. (PBYI) Q4 2023 Earnings Call Transcriptseekingalpha.com - March 2 at 1:51 AMPuma Biotechnology (NASDAQ:PBYI) PT Lowered to $7.00 at HC Wainwrightmarketbeat.com - March 1 at 3:39 PMPuma Biotechnology Reports Fourth Quarter and Full Year 2023 Financial Resultsbusinesswire.com - February 29 at 4:05 PMPuma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)finance.yahoo.com - February 27 at 11:20 PMPuma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)businesswire.com - February 27 at 6:30 PMPuma Biotechnology to Participate in a Panel Discussion at TD Cowen’s 44th Annual Health Care Conferencefinance.yahoo.com - February 22 at 9:35 PMPuma Biotechnology to Participate in a Panel Discussion at TD Cowen's 44th Annual Health Care Conferencebusinesswire.com - February 22 at 4:10 PMFY2025 Earnings Forecast for Puma Biotechnology, Inc. Issued By Zacks Research (NASDAQ:PBYI)marketbeat.com - February 22 at 8:17 AMPuma Biotech (PBYI) Is Up 23.01% in One Week: What You Should Knowmsn.com - February 21 at 2:33 PMPuma Biotechnology, Inc. (NASDAQ:PBYI) to Post FY2024 Earnings of $0.42 Per Share, Zacks Research Forecastsmarketbeat.com - February 21 at 7:59 AMPuma Biotechnology to Host Conference Call to Discuss Fourth Quarter and Full Year 2023 Financial Resultsfinance.yahoo.com - February 15 at 7:16 PMPuma Biotechnology to Host Conference Call to Discuss Fourth Quarter and Full Year 2023 Financial Resultsbusinesswire.com - February 15 at 4:10 PMPuma Biotechnology (NASDAQ:PBYI) Stock Rating Lowered by StockNews.commarketbeat.com - February 14 at 1:26 AMPuma Biotechnology Inc.wsj.com - February 13 at 8:49 AMPuma Biotechnology Announces Initiation of ALISCA-Lung1 Phase II Trial of Alisertib in Small Cell Lung Cancerfinance.yahoo.com - February 13 at 8:49 AMPBYI vs. AMGN: Which Stock Should Value Investors Buy Now?msn.com - February 9 at 1:11 PMAssenagon Asset Management S.A. Sells 154,179 Shares of Puma Biotechnology, Inc. (NASDAQ:PBYI)marketbeat.com - February 9 at 4:47 AMImmunome (IMNM) to Acquire Desmoid Tumor Candidate, Stock Upfinance.yahoo.com - February 7 at 1:49 PM3 small-cap biotechs with potential breakthroughs in 2024 (PBYI)marketbeat.com - February 6 at 10:15 AMNovo Nordisk (NVO) to Acquire 3 Catalent Sites for $11Bfinance.yahoo.com - February 5 at 2:47 PM Get Puma Biotechnology News Delivered to You Automatically Sign up to receive the latest news and ratings for PBYI and its competitors with MarketBeat's FREE daily newsletter. Email Address This is the ONLY AI story you should be worried about (Ad)A.I. is creeping into every aspect of our daily lives… According to billion-dollar fund manager, Louis Navellier, it’s never been more important to A.I.-proof your wealth. He lays out three simple steps to take ASAP in his latest video. Click here to watch it now. PBYI Media Mentions By Week PBYI Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PBYI News Sentiment▼0.430.40▲Average Medical News Sentiment PBYI News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PBYI Articles This Week▼172▲PBYI Articles Average Week Get Puma Biotechnology News Delivered to You Automatically Sign up to receive the latest news and ratings for PBYI and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: AC Immune News Today Aquestive Therapeutics News Today 23andMe News Today Immutep News Today Verastem News Today 2seventy bio News Today Aldeyra Therapeutics News Today XBiotech News Today Foghorn Therapeutics News Today Pyxis Oncology News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:PBYI) was last updated on 5/6/2024 by MarketBeat.com Staff From Our PartnersCould Your Accounts Be Frozen?Allegiance GoldThe asset beating inflation by 4xColonial MetalsHe Is Giving Away BitcoinCrypto Swap ProfitsMissed NVDA? Buy this AI stock NOWChaikin AnalyticsElon to Transform U.S. Economy? Porter & CompanyIncredible Opportunity to Retire FAST!Crypto 101 MediaAI “wealth window” is closing June 25thParadigm PressGlobal crypto currency reset (41 major banks signed up)Stansberry Research Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Puma Biotechnology, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
